Assistant Professor, Obstetrics and Gynecology, UA College of Medicine-Phoenix
Obstetrics & Gynecology
Dr. Dana M. Chase, MD
|
|
Give Review
Dana M. Chase works in the field of Obstetrics & Gynecology. She went to University of California Irvine School of Medicine. University of California Irvine School of Medicine has a rank of 45 in research and a 62 in primary care She has 1 awards "Fellow (FACOG)". Dana Chase is a published doctor. She published 24 publications, including: 'Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
- Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: Characteristics associated with toxicity and the effect of substitution with...
- Factors Associated With Grade 3 or 4 Treatment-Related Toxicity in Women With Advanced or Recurrent Cervical Cancer: An Exploratory Analysis of NRG Oncology/Gynecologi...
- Factors associated with poor quality of life among cervical cancer survivors: Implications for clinical care and clinical trials.
- Appropriate Use of Complementary and Alternative Medicine Approaches in Gynecologic Cancers.
- Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.
- Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical ...
- Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer.
- Changes in tumor blood flow as measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) may predict activity of single agent bevacizumab in recurrent...
- Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer.
- Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy?
- Recruitment and retention results for a population-based cervical cancer biobehavioral clinical trial.
- Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of c...
- Severe fetal skull fracture and death subsequent to a motor vehicle crash with frontal airbag deployment.
- Socioeconomic factors may contribute to neoadjuvant chemotherapy use in metastatic epithelial ovarian carcinoma.
- Colposcopy to evaluate abnormal cervical cytology in 2008.
- Preoperative diagnosis of ovarian malignancy: preliminary results of the use of 3-dimensional vascular ultrasound.
- A clinical pathway for postoperative management and early patient discharge: does it work in gynecologic oncology?
- Health-related quality of life in ovarian cancer patients and its impact on clinical management.
- Supportive care for women with gynecologic cancers.
- Drug discovery in ovarian cancer.
- Assessment and significance of quality of life in women with gynecologic cancer.
- High pathologic misdiagnosis of cervical adenocarcinoma in situ.
Schools
University Of Californiairvine Medical Center
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Advanced Robotic Surgery
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACOG)
Education
-
University of California Irvine -
University of California Irvine School of Medicine
Hospital
-
UC Irvine Medical Center -
St. Joseph's Hospital and Medical Center -
Chandler Regional Medical Center
Drug Facts
| NPI NUMBER | 1396888947 | |
| NPPES Provider LastName | CHASE | |
| NPPES Provider FirstName | DANA | |
| NPPES Provider ZIPCode | 850134221 | |
| NPPES Provider State | AZ | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 66.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396888947 |
| Last Name Of The Provider | CHASE |
| First Name Of The Provider | DANA |
| View All |
Similar Doctors
|
Dr. Matthew P. Borst, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Emily C. Cyr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul M. Magtibay, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Charles A. Alfano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ekwutosi M. Okoroh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Rigby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Crista E. Johnson-Agbakwu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John H. Farley, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Vanna L. Zanagnolo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rachel L. Rodel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan N. Gordon, MD
This Doctor is OpenDoctor Recommended.
|